ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 131,41
0,69%
Dow Jones
39 056,39
0,44%
DAX
18 498,38
0,32%
Brent Oil
83,56
0,84%
Bitcoin
61 055,42
-2,05%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Supernus Pharmaceuticals Inc (SUPN)

  7. Supernus Pharmaceuticals Inc (SUPN) Actualités

SUPN Supernus Pharmaceuticals Inc

31,30
0,15 (0,48%)
Après les heures de négociation
Dernière mise à jour : 00:46:22
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Supernus Pharmaceuticals Inc SUPN NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,15 0,48% 31,30 00:46:22
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
30,97 30,76 31,56 31,30 31,15
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
08/5/202422:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202422:08EDGAR2Form 8-K - Current report
08/5/202422:05GLOBESupernus Announces First Quarter 2024 Financial Results
07/5/202416:00PRNUSM8 Pharmaceuticals, an Acino company, signs an exclusive..
01/5/202414:00GLOBEBusy Philipps Shines Spotlight on ADHD in Women and Shares..
24/4/202422:05GLOBESupernus Pharmaceuticals to Announce First Quarter 2024..
08/4/202414:00GLOBESupernus Provides Regulatory Update for SPN-830
06/3/202422:30GLOBESupernus to Participate in Two Upcoming Investor Conferences
29/2/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202423:00EDGAR2Form 8-K - Current report
28/2/202422:30GLOBESupernus to Participate in the TD Cowen 44th Annual..
27/2/202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:14EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/2/202422:05GLOBESupernus Announces Fourth Quarter and Full Year 2023..
26/2/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202422:27EDGAR2Form 144 - Report of proposed sale of securities
22/2/202423:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202420:33EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202413:06EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/2/202422:08EDGAR2Form 8-K - Current report
13/2/202422:05GLOBESupernus Pharmaceuticals to Announce Fourth Quarter and Full..
05/2/202415:21EDGAR2Form 8-K - Current report
05/2/202414:30GLOBESupernus Wins Infringement and Validity Case on Trokendi XR®..
12/1/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202422:08EDGAR2Form 144 - Report of proposed sale of securities
26/12/202323:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202313:30GLOBEKnight Therapeutics Enters into Exclusive License Agreement..
18/12/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202311:50IHMARKETNEWSHasbro Job Cuts, Oracle’s Stock Decline, Google’s Epic..
17/11/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202322:22EDGAR2Form 144 - Report of proposed sale of securities
14/11/202320:59EDGAR2Form 144 - Report of proposed sale of securities
08/11/202322:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202322:10EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

NASDAQ
SUPN
Supernus Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés